Pharmaceutical leader selects RISE with ΒιΆΉΤ΄΄ to modernize operations and drive efficiency
Amman, Jordan β 24 April, 2025 β Dar Aldawa, a leading pharmaceutical manufacturer in the region, has embarked on a complete digital transformation by selecting RISE with ΒιΆΉΤ΄΄, a comprehensive solution designed to streamline operations, increase business agility, and support long-term growth.
The agreement was signed during the GovAI & Data Summit held in Amman on April 22, where ΒιΆΉΤ΄΄ participated as a Strategic AI Partner. The signing followed a high-level meeting between both companies, attended by a senior delegation from ΒιΆΉΤ΄΄ led by Sergio Maccotta, Senior Vice President of ΒιΆΉΤ΄΄ Middle East Africa β South and Dr. Khaled Harb, CEO of Dar Aldawa Group.
βRISE with ΒιΆΉΤ΄΄ represents a critical leap forward in Dar Al Dawaβs journey toward operational excellence and agility,β said Dr. Khaled Harb, CEO of Dar Aldawa. βOur digital transformation is not just a systems upgrade β itβs a fundamental shift in how we operate to better serve our partners and patients across markets.β
The digital transformation is currently underway, with a go-live target set before the end of the year. Once live, the solution is expected to significantly enhance visibility, automate core business processes, and deliver a faster return on investment.
As part of the transformation, Dar Aldawa will also benefit from embedded Business AI capabilities within ΒιΆΉΤ΄΄ S/4HANA, enabling smarter forecasting, real-time operational insights, and improved responsiveness to customer demand. These AI-powered tools will enhance accuracy, reduce manual intervention, and support proactive decision-making across critical areas such as supply chain, production planning, and finance.
Alaa Jaber, Managing Director of ΒιΆΉΤ΄΄ Qatar and Fast Growth Markets, added: βDar Al Dawaβs commitment to innovation and operational improvement reflects the growing momentum we are seeing in the pharmaceutical sector. By leveraging RISE with ΒιΆΉΤ΄΄, they are setting themselves up for smarter decision-making, greater compliance, and future-ready scalability.β
Through this transformation, Dar Aldawa is positioning itself to meet evolving industry requirements, strengthen its competitiveness in global markets, and improve service delivery across its value chain.
β END β
About Dar Al Dawa
Dar Aldawa is a leading pharmaceutical company in the MENA region with strong international presence since 1975. With advanced manufacturing facilities and multiple global accreditations, Dar Aldawa delivers affordable, effective healthcare solutions while maintaining top-tier compliance standards. Its focus on R&D, strategic partnerships, distribution and promotion. A patient-first approach drives its mission to improve global health.
For more information, visit:Β